Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $607.3900 (3.37%) ($589.0600 - $609.0950) on Thu. Jun. 23, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.05% (three month average) | RSI | 41 | Latest Price | $607.3900(3.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.6% a day on average for past five trading days. | Weekly Trend | REGN declines -2.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(56%) DIA(38%) IWD(35%) IVW(34%) SPY(34%) | Factors Impacting REGN price | REGN will decline at least -1.025% in a week (0% probabilities). VIXM(-11%) TBT(-10%) UUP(-5%) VXX(-1%) EDOC(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.025% (StdDev 2.05%) | Hourly BBV | 2.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $608.09 | 5 Day Moving Average | $584.03(4%) | 10 Day Moving Average | $573.42(5.92%) | 20 Day Moving Average | $608.09(-0.12%) | To recent high | -17.8% | To recent low | 10.9% | Market Cap | $64.401b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |